E. Zang
Impact in
- Biochemistry top 5%
- Phytochemicals and Antioxidant Activities
- Cancer Research top 5%
- Carcinogens and Genotoxicity Assessment
Papers in
- Oncology 10
- Colorectal Cancer Treatments and Studies 2
- Cancer Treatment and Pharmacology 2
- Cancer-related Molecular Pathways 2
- Co-authors
- E L Wynder (1 shared paper)Gary J. Kelloff (3 shared papers)Kenji Tokumo (2 shared papers)Chinthalapally V. Rao (1 shared paper)J. H. Weisburger (3 shared papers)Ernst L. Wynder (2 shared papers)Abraham Rivenson (5 shared papers)Alvin E. Friedman‐Kien (2 shared papers)
- Journals
- JNCI Journal of the National Cancer Institute (5 papers)Journal of Clinical Oncology (5 papers)Experimental Biology and Medicine (2 papers)The Prostate (1 paper)Transfusion (1 paper)
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
E. Zang
36 papers receiving 1.9k citations
E. Zang's Hit Papers
Peers
Comparison fields: 5 of 126
- Biochemistry 164
- Cancer Research 286
- Oncology 462
- Pathology and Forensic Medicine 269
- Applied Microbiology and Biotechnology 28
Countries citing papers authored by E. Zang
This map shows the geographic impact of E. Zang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Zang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Zang more than expected).
Fields of papers citing papers by E. Zang
This network shows the impact of papers produced by E. Zang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Zang. The network helps show where E. Zang may publish in the future.
Co-authors
The 25 scholars most cited alongside E. Zang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Differences in Lung Cancer Risk Between Men and Women: Examination of the Evidence Hit paper breakdown → | 1996 | 580 |
| 2 | Chemoprevention of colon carcinogenesis by concurrent administration of piroxicam, a nonsteroidal antiinflammatory drug with D,L-alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor, in diet. | 1990 | 206 |
| 3 | Chemoprevention of colon carcinogenesis by dietary administration of piroxicam, alpha-difluoromethylornithine, 16 alpha-fluoro-5-androsten-17-one, and ellagic acid individually and in combination. | 1991 | 177 |
| 4 | 1986 | 153 | |
| 5 | 1994 | 124 | |
| 6 | 1995 | 92 | |
| 7 | 1994 | 74 | |
| 8 | 1991 | 67 | |
| 9 | 1985 | 65 | |
| 10 | 1992 | 59 | |
| 11 | 1989 | 52 | |
| 12 | 1996 | 47 | |
| 13 | 2011 | 47 | |
| 14 | 1987 | 45 | |
| 15 | 1998 | 40 | |
| 16 | 2001 | 31 | |
| 17 | 1999 | 30 | |
| 18 | 1994 | 29 | |
| 19 | 1994 | 27 | |
| 20 | 1990 | 23 |
About E. Zang
E. Zang is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Epidemiology and Hematology, having authored 36 papers that have together received 2.1k indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (4 papers), Hepatitis B Virus Studies (2 papers), Microtubule and mitosis dynamics (2 papers), Colorectal Cancer Treatments and Studies (2 papers), Blood donation and transfusion practices (2 papers), Blood groups and transfusion (2 papers), Cancer Treatment and Pharmacology (2 papers) and Cancer-related Molecular Pathways (2 papers). The work is most often cited by research in Biochemistry (164 citations), Cancer Research (286 citations), Oncology (462 citations), Pathology and Forensic Medicine (269 citations) and Applied Microbiology and Biotechnology (28 citations). E. Zang has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include E L Wynder, Gary J. Kelloff, Kenji Tokumo, Chinthalapally V. Rao, J. H. Weisburger, Ernst L. Wynder, Abraham Rivenson, Alvin E. Friedman‐Kien, Lirio S. Covey and Carol Meschter. Their work appears in journals such as JNCI Journal of the National Cancer Institute, Journal of Clinical Oncology, Experimental Biology and Medicine, The Prostate and Transfusion.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.